Susan L. Greenspan
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Susan L. Greenspan sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).
Susan L. Greenspan: 6 sponsored US clinical trials, 1 recruiting.
Susan L. Greenspan sponsors 6 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 4 completed. 6 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Osteoporosis, with 2 trials.
Upper-quartile sponsor footprint
Susan L. Greenspan sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
6 total, page 1 of 1
Preserving Geriatric Muscle With an Osteoporosis Medication
NCT06118905
Romosozumab Use to Build Skeletal Integrity
NCT05058976
Preventing Osteoporosis Using Denosumab
NCT02753283
Zoledronic Acid for Osteoporotic Fracture Prevention (ZEST II)
NCT02589600
Fracture (FX) Improvement With Teriparatide: FiX-IT Study
NCT01705587
Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor Therapy
NCT00485953
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 6 |
Therapeutic Areas
Where Susan L. Greenspan enrollment is open (later-stage tilt)
1 recruiting of 6 indexed (17% open); 4 completed (67%).
Phase mix: 6 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Osteoporosis (2 trials), 2 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Susan L. Greenspan: open-pipeline peers nationwide
Peers matched on 6 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Susan L. Greenspan sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 6 trials (± recruiting share)
- 23andMe · 6 trials · 0% recruiting
- Aardvark Therapeutics · 6 trials · 0% recruiting
- Abbisko Therapeutics Co · 6 trials · 67% recruiting
- AbGenomics B.V Taiwan Branch · 6 trials · 0% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Adagene · 17% recruiting · 6 trials
- Agendia · 17% recruiting · 6 trials
- Akamis Bio · 17% recruiting · 6 trials
- Angiodynamics · 17% recruiting · 12 trials
Related
What to do with this Susan L. Greenspan page
6 registered trials is a research-attention snapshot, not an endorsement of Susan L. Greenspan or any single study.
- 1 of Susan L. Greenspan's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Osteoporosis is the condition Susan L. Greenspan studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Osteoporosis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Susan L. Greenspan pipeline card: 6 registered trials from official public datasets.Report a data error.